1
Registered trials
0
Recruiting
1
Unique sponsors
5
Unique IMPs
0
Commercial trials
Drug classes (ATC)
L
Oncology (ATC L)
1
V
Various (ATC V)
1
Mechanism of action (INN-stem analysis)
Monoclonal antibody (immune)
2 substances
Antimetabolite
1 substance
Supportive / rescue
1 substance
Platinum compound
1 substance
Phase II:
1
Phase II
1 trial-
HaltedHospices Civils De Lyon AcademicDOMVANALIMAB; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN; ZIMBERELIMAB
Sponsor activity
| Sponsor | Type | Trials | Phases | Recruiting |
|---|---|---|---|---|
| Hospices Civils De Lyon | Academic | 1 | Phase II | 0 |
New trials by year
2025
1